HPI Engine Incubator 2026 | Build the Future of Tech Entrepreneurship
Application Deadline: August 2, 2026
1 Min
More New findings on personalized medicine for rare jaw tumors
Molecular tumor profiling and targeted therapies could enable less invasive surgery of ameloblastomas
2 Min
More BioM, bioRN and ESMT Berlin join forces to create a Unified Hub for healthcare innovation in Germany
BioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two biotech cluster organizations and DEEP - Institute for Deep Tech…
5 Min
More How the skin distinguishes cool from warm
Researchers in the lab of James Poulet have uncovered how the nervous system senses cool and warm temperatures. The findings, published in “Neuron” challenge a long-standing view of temperature sensing and could guide future research into pain and…
2 Min
More OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA
Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 study.
With the vast majority of PMD patients having no FDA-approved therapeutic option, OMT-28 addresses…
4 Min
More Applications open for the Berlin Startup Scholarship by Science & Startups!
Application deadline: August 3, 2026
1 Min
More Electrical stimulation helps organoids mature
Researchers in the Mina Gouti lab show in “Advanced Science” that electrical pulse stimulation helps human neuromuscular organoids mature. This non-invasive approach may make it possible to use organoid models to study adult-onset diseases and to…
3 Min
More The smell of success
Reporting in “Nature,” a team led by Gary Lewin at the Max Delbrück Center has found that naked mole-rat queens produce an odorous chemical that ensures that only they can reproduce. The queen odor also prevents rivalry within colonies — even when…
5 Min
More Artificial Intelligence in the Clinic: x-cardiac Transforms into Ascléa GmbH and Successfully Closes Series A Funding Round
x-cardiac GmbH, a company in the field of AI-powered medical devices, has broadened its business focus to AI solutions for everyday clinical use while simultaneously rebranding as Ascléa GmbH. At the same time, a Series A funding round has been…
2 Min
More Successful evaluation of DRFZ
Leibniz Association recommends continued funding of the DRFZ
2 Min
More Show more items
